Division of Otolaryngology-Head and Neck Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Division of Otolaryngology-Head and Neck Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Cytotherapy. 2017 Dec;19(12):1522-1528. doi: 10.1016/j.jcyt.2017.08.016. Epub 2017 Oct 3.
Mesenchymal stromal cells (MSCs) have shown potential therapeutic benefits for a range of medical disorders and continue to be a focus of intense scientific investigation. Transplantation of MSCs into injured tissue can improve wound healing, tissue regeneration and functional recovery. However, implanted cells rapidly lose their viability or fail to integrate into host tissue. Hydrogel-seeded bone marrow (BM)-MSCs offer improved viability in response to mechanical forces caused by syringe needles, cell density and dimethylsulfoxide (DMSO) concentration, which in turn, will help to clarify which factors are important for enhancing biomaterial-induced cell transplantation efficiency and provide much needed guidance for clinical trials. In this study, under the control of cell density (<2 × 10 cells/mL) and final DMSO concentration (<0.5%), hydrogel-induced BM-MSC viability remained >82% following syringe needle passage by 25- or 27-gauge needles, providing improved cell therapeutic approaches for regenerative medicine.
间充质基质细胞 (MSCs) 在一系列医学疾病的治疗中显示出潜在的益处,并且仍然是科学研究的焦点。将 MSCs 移植到受损组织中可以改善伤口愈合、组织再生和功能恢复。然而,植入的细胞会迅速失去活力或无法整合到宿主组织中。水凝胶种植的骨髓 (BM)-MSCs 对注射器针、细胞密度和二甲亚砜 (DMSO) 浓度引起的机械力具有更高的存活率,这反过来又有助于阐明哪些因素对于提高生物材料诱导的细胞移植效率很重要,并为临床试验提供急需的指导。在这项研究中,在细胞密度(<2×10 个细胞/ml)和最终 DMSO 浓度(<0.5%)的控制下,通过 25 或 27 号针进行注射器针穿刺后,水凝胶诱导的 BM-MSC 存活率仍保持在>82%,为再生医学提供了更好的细胞治疗方法。